Lille University Hospital
Lille, 59000, France
Location status: Recruiting
NCT Number: NCT06338397
Recent studies have shown that individual neuropsychological scores of patients with Alzheimer's disease and Associated Disorders (ADAD) are only poorly correlated to their behavioral difficulties, such as disinhibition, apathy, social decision-making or vulnerability. Recently, social & affective cognitive disorders have been highlighted as potential cause of social behavioral abnormalities. However, no previous studies have assessed the specific relationship between social & affective cognition & social behavior in ADAD. Our pilot study aims to explore the correlations between core and extended social & affective cognitive processes and social behavior as observed during the neuropsychological examination, as well as to explore the common brain regions involved in those domains.
Interested in participating?
Request Info40 year–85 year
All sexes
Interventional
Not applicable
Lille, 59000, France
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administering 11 tests of social & affective cognition to each participant as well as 6 scales to their study-partner, in order to have a detailed profile of social & affective cognitive abilities that we can correlate to an 3DMRI with resting state procedure.
Time frame: 1day
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Contact information is provided by the study sponsor or research team.
University Hospital, Lille
Other
Social & Affective Cognition as Determinant of Social Behavior in Alzheimer's Disease & Associated Disorders
Acronym: SOCIALIZE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03233646
APOE-4 Positive, Abnormalities, Multiple
Durham, North Carolina, United States
View Trial DetailsNCT00950430
Alzheimer Disease, Alzheimer's Disease
Rochester, Minnesota, United States
View Trial DetailsNCT02912936
Acid-Base Imbalance, Acidosis
Vancouver, British Columbia, Canada
View Trial DetailsNCT03828383
Alzheimer Disease, Alzheimer's Disease
Berkeley, California, United States
View Trial Details